Skip to content

Perceptions of Illness Severity, Treatment Goals and Life Expectancy

The ePISTLE Study: Perceptions of Illness Severity, Treatment Goals and Life Expectancy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04225416
Acronym
ePISTLE
Enrollment
120
Registered
2020-01-13
Start date
2018-11-16
Completion date
2024-11-01
Last updated
2022-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis, Peritoneal Dialysis

Keywords

hemodialysis, peritoneal dialysis

Brief summary

This study is exploring symptom burden, health experiences and expectations of treatment and survival of seriously ill dialysis patients and their physicians.

Detailed description

Sharing and communicating information with patients is an integral part of medical care, yet research has shown that disparities exist between physicians and patient perceptions of illness severity. In renal medicine, along with many other specialties, expected prognosis can affect treatment offered.Thus appreciating and understanding one's prognosis can influence patients and relatives' expectations for treatment and guide discussions regarding quality of life. Previous work has highlighted disparities in the United States between expectations of survival of seriously ill haemodialysis patients and their physicians. The investigators plan to repeat this study within the United Kingdom, to see whether similar issues occur and to elucidate current practice on discussions of prognosis, symptom burden and transplant candidacy. The investigators hope to identify where care can be improved and to enable patients to better make informed decisions on treatment and goals of care. Part one of the study is to repeat this study in haemodialysis patients in the United Kingdom. This has been completed and published (2021) at https://www.kireports.org/article/S2468-0249(21)00103-0/fulltext. Part two of the study is to extend the study to peritoneal dialysis patients in the United Kingdom.

Interventions

OTHERQuestionnaire/Structured Interview

No intervention

Sponsors

Imperial College London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Haemodialysis patients 18-100 years old, with a predicted mortality risk of \>20% in the next year, their close person and staff members (nurse and doctor) caring for the patient. * Peritoneal dialysis patients 18-100 years old, with a predicted mortality risk of \>20% in the next year, their close person and staff members (nurse and doctor) caring for the patient.

Exclusion criteria

* Patients on home haemodialysis

Design outcomes

Primary

MeasureTime frameDescription
Current practice regarding discussion of prognosis with seriously ill dialysis patients, to better understand the dissonance between physician and patient beliefs on prognosis, transplant candidacy and goals of care.Through study completion, an average of 2 yearsCompletion of questionnaire or structured interview

Secondary

MeasureTime frameDescription
Number of dialysis patients who are more optimistic about prognosis and transplant candidacy than their nephrologistsThrough study completion, an average of 2 yearsCompletion of questionnaire or structured interview
Patients' prognostic expectations are associated with their treatment preferencesThrough study completion, an average of 2 yearsCompletion of questionnaire or structured interview
Number of patients with dialysis associated symptoms as assessed by IPOS Renal (https://pos-pal.org/maix/ipos-renal-in-english.php).7 daysCompletion of questionnaire or structured interview

Countries

United Kingdom

Contacts

Primary ContactHannah Beckwith, MBChB
hannah.beckwith@nhs.net02033131000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026